NCT07243470
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07243470
Title Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors (TARLATEM)
Acronym TARLATEM
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de Cancérologie de l'Ouest NOT_YET_RECRUITING Angers 49055 France Details
Hôpital Universitaire d'Angers NOT_YET_RECRUITING Angers 49933 France Details
CHU de Bordeaux NOT_YET_RECRUITING Bordeaux 33000 France Details
Hôpital Saint-André NOT_YET_RECRUITING Bordeaux 33075 France Details
Hôpital Neurologique Pierre Wertheimer NOT_YET_RECRUITING Bron 69677 France Details
Centre Oscar Lambret NOT_YET_RECRUITING Lille 59000 France Details
Centre Léon Bérard RECRUITING Lyon 69373 France Details
Hôpital de la Timone NOT_YET_RECRUITING Marseille 13005 France Details
Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix NOT_YET_RECRUITING Paris 75013 France Details
IUCT - Claudius Regaud NOT_YET_RECRUITING Toulouse 31100 France Details
Institut Gustave Roussy NOT_YET_RECRUITING Villejuif 94085 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field